| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $606.4M | +66.7% |
| Cost of Revenue | $122.9M | +43.4% |
| R&D Expense | $771.1M | +28.9% |
| SG&A Expense | $701.2M | +52.1% |
| Operating Income | -$1.25B | -42.0% |
| Interest Expense | $83.8M | -1.3% |
| Pre-tax Income | -$1.27B | -39.7% |
| Income Tax | $5.0M | +35.6% |
| Net Income | -$1.28B |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $510.4M | -8.0% |
| Short-term Investments | $919.6M | +4.6% |
| Accounts Receivable | $140.9M | +170.8% |
| Inventory | $132.1M | +34.0% |
| Current Assets | $1.79B | +10.6% |
| Total Assets | $2.26B | +11.8% |
| Current Liabilities | $468.9M | +57.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$935.0M | -36.7% |
| Capital Expenditures | $32.6M | +48.5% |
| Investing Cash Flow | -$64.6M | +88.9% |
| Financing Cash Flow | $954.1M | -28.9% |
| Free Cash Flow | -$967.6M | -37.1% |
| -39.7% |
| EPS (Basic) | -$6.42 | -15.3% |
| EPS (Diluted) | -$6.42 | -15.3% |
| Long-term Debt |
| $546.8M |
| -51.3% |
| Total Liabilities | $1.53B | -12.3% |
| Stockholders' Equity | $739.0M | +158.9% |